V009-3042 Screening compound: N-{1-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide

V009-3042 Screening compound: N-{1-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide
V009-3042 Screening compound: N-{1-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-3042
N-{1-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-3042

Molecular Formula

C27H33N3O2 (C27 H33 N3 O2)

Compound Name

N-{1-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide

IUPAC name

N-{1-[3-(24-dimethylphenyl)-4-oxo-34-dihydroquinazolin-2-yl]ethyl}-N-(3-methylbutyl)cyclopropanecarboxamide

SMILES

CC(C)CCN(C(C)C(N1c2c(C)cc(C)cc2)=Nc(cccc2)c2C1=O)C(C1CC1)=O

InChI

InChI=1S/C27H33N3O2/c1-17(2)14-15-29(26(31)21-11-12-21)20(5)25-28-23-9-7-6-8-22(23)27(32)30(25)24-13-10-18(3)16-19(24)4/h6-10,13,16-17,20-21H,11-12,14-15H2,1-5H3/t20-/m0/s1

InChI Key

YBBMQOAEHBAHOP-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD01518459

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

431.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.315

Distribution Coefficient, logD

5.191

Water Solubility, LogSw

-5.30

Polar Surface Area

40.785

Acid Dissociation Constant (pKa)

19.07

Base Dissociation Constant (pKb)

6.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.40

V009-3042 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Angiogenesis library (14822 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V009-3042 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-3042?
Check Price and Availability of V009-3042, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-3042 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-3042
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-3042
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-3042 available by request